Optimizing Patient's Comfort During Scleral Indentation

NCT ID: NCT06683209

Last Updated: 2025-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-07-01

Study Completion Date

2026-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The scleral depression exam is an important routine technique for evaluating the retinal periphery for various reasons. During this examination, an instrument is used to bring the anterior part of the retina into the physician's field of view. The downside of this technique is the discomfort it may cause the patient. Different instruments can be used to depress the sclera.

The objective of this research is to compare three commonly used scleral depressors based on their performance for the ophthalmologist and the discomfort they subjectively induce in patients.

Patients will be randomly allocated to one of three examination groups:

Group A: One eye examined with the Schocket scleral depressor, the other eye with the Josephberg-Besser scleral depressor.

Group B: One eye examined with the Schocket scleral depressor, the other eye with the cotton-tip applicator.

Group C: One eye examined with the cotton-tip applicator, the other eye with the Josephberg-Besser scleral depressor.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background The scleral depression exam is an important technique for evaluating the retinal periphery during indirect ophthalmoscopy. Despite the advent of ultra-widefield fundus imaging, scleral depression provides greater sensitivity in detecting peripheral lesions, such as retinal tears. It was found that 11% of retinal tears were missed when employing non-contact slit-lamp examination, compared to indirect ophthalmoscopy with scleral depression, and a scleral depression exam is widely considered the gold standard for ruling out retinal tears. While there is no international consensus, the preferred practice guideline (American Academy of Ophthalmology) for assessing peripheral vitreoretinal pathology is by indirect ophthalmoscopy combined with scleral depression.

There are a variety of ophthalmic instruments that an eye care professional may use to perform scleral depression. While the exam is uncomfortable, there is a lack of studies comparing patient comfort with different instruments. In this prospective study, we will compare subjective patient pain scores using the Schocket scleral depressor, the Josephberg-Besser scleral depressor, and the cotton-tipped applicator.

Purpose To assess patient pain scores for three common scleral indentation devices and determine which is most comfortable for patients.

Objective / Hypothesis Based on clinical experience, the hypothesis is that the Josephberg-Besser scleral depressor causes less discomfort due to its design.

Study Design Prospective comparative analysis.

Methods Patients will be recruited at two tertiary referral centers (Alberta Retinal Consultants, Edmonton, Alberta, and Sunnybrook Hospital, Department of Ophthalmology \& Vision Sciences, Toronto, Ontario) upon consent to participate. Subject identification will be based on the referral indication (symptomatic posterior vitreous detachment with or without vitreoretinal pathology) and the absence of exclusion criteria (i.e., patients who require a scleral indentation examination based on the presenting symptoms). Patients will then be randomly allocated to one of three groups. Additionally, within each group, the symptomatic eye will be randomized.

Patients will be dilated with 1% tropicamide and 2.5% phenylephrine for 30 minutes. Instillation of local anesthetic drops will be used to eliminate any confounding exposure-related keratalgia or ocular surface irritation. Indirect ophthalmoscopic evaluation of the retinal periphery will be undertaken using the provider's lens of choice (20 or 28-diopter lens). The lens and illumination settings will be kept the same for each eye. A similar amount of time and effort will be spent on both eyes.

Following the examination, both patients and physicians will be asked to provide responses to the survey questions provided (surveys enclosed).

Statistical analysis will be performed using R statistical software. Randomization to treatment will be created using Python programming software.

Exclusions:

Monocular status. Media opacity that precludes view of the peripheral retina. Inadequate examination (cooperation with examination, inability to achieve all directions of gaze).

Underlying oculodynia (recent surgery, intraocular inflammation, abnormal intraocular pressure, ocular dysesthesia syndromes (ocular, adnexal, or orbital)).

History of pain-sensitizing conditions or current analgesic use. Previous scleral indentation examination poorly tolerated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

In each group, patient receive two different types of scleral depressor, one in each eye.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

One eye examined with the Schocket scleral depressor, the other eye with the Josephberg-Besser scleral depressor

Group Type ACTIVE_COMPARATOR

Schocket scleral depressor

Intervention Type DIAGNOSTIC_TEST

Use of this instrument to examine one eye

Josephberg-Besser

Intervention Type DIAGNOSTIC_TEST

Use of this instrument to examine one eye

Group B

One eye examined with the Schocket scleral depressor, the other eye with the cotton tip applicator

Group Type ACTIVE_COMPARATOR

Schocket scleral depressor

Intervention Type DIAGNOSTIC_TEST

Use of this instrument to examine one eye

Cotton tip applicator

Intervention Type DIAGNOSTIC_TEST

Use of this instrument to examine one eye

Group C

One eye examined with the cotton tip applicator, the other eye with the Josephberg-Besser scleral depressor

Group Type ACTIVE_COMPARATOR

Josephberg-Besser

Intervention Type DIAGNOSTIC_TEST

Use of this instrument to examine one eye

Cotton tip applicator

Intervention Type DIAGNOSTIC_TEST

Use of this instrument to examine one eye

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Schocket scleral depressor

Use of this instrument to examine one eye

Intervention Type DIAGNOSTIC_TEST

Josephberg-Besser

Use of this instrument to examine one eye

Intervention Type DIAGNOSTIC_TEST

Cotton tip applicator

Use of this instrument to examine one eye

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Symptomatic posterior vitreous detachment with or without vitreoretinal pathology

Exclusion Criteria

* Monocular status.
* Media opacity which precludes view of the peripheral retina.
* Inadequate examination (cooperation with examination, inability to achieve all directions of gaze).
* Underlying oculodynia (recent surgery, intraocular inflammation, abnormal intraocular pressure, ocular dysesthesia syndromes (ocular, adnexal or orbital).
* History of pain-sensitizing conditions or current analgesic use.
* Previous scleral indented examination poorly tolerated.
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Toronto

OTHER

Sponsor Role collaborator

Alberta Retina Consultant

UNKNOWN

Sponsor Role collaborator

University of Alberta

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alberta Retina Consultant

Edmonton, Alberta, Canada

Site Status

Sunnybrook Hospital

Toronto, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mathieu Carrière, MD, FRCSC

Role: CONTACT

(780) 448-1801

Parampal Grewal

Role: CONTACT

(780) 448-1801

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mathieu Carriere, MD, FRCSC

Role: primary

(780) 448-1801

Kenneth T. Eng, MD, FRCSC

Role: primary

(416) 480-4762

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro00146504

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pain Perception at Laser Treatment
NCT01033968 COMPLETED PHASE4
OCT Angiography in Wet AMD
NCT02253030 RECRUITING
Retinal Imaging Using NOTAL-OCT
NCT03374020 COMPLETED
Peripheral Retina Robotically Aligned OCT Study
NCT06451068 NOT_YET_RECRUITING NA